Skip to main content
Top
Published in: BMC Cancer 1/2014

Open Access 01-12-2014 | Research article

Incidence and outcome for patients with occult lymph node involvement in T1 and T2 oral squamous cell carcinoma: a prospective study

Published in: BMC Cancer | Issue 1/2014

Login to get access

Abstract

Background

The evidence base to inform the decision making process in patients with early stage oral cancer and a clinical and radiological N0 neck remains insufficient to answer the question when it is safe to “watch and wait” and when to proceed with a selective neck dissection.

Methods

A total of 327 consecutive cases of histopathologically staged T1–2, N0–1 and M0, but clinically N0, squamous cell carcinoma of the tongue were prospectively analysed. Univariate and multivariate analyses were used for statistical analysis and are represented as Kaplan-Meier analyses or Cox proportional hazard regression analysis.

Results

In 61 patients (18.65%) lymph node involvement was found in the histopathological processing. The mean survival of all patients was 73.3 ± 48.6 months. The 2-year and 5-year overall survival rates of all patients were 87.5% and 68.4%, respectively. The 2-year and 5-year survival rates for stage N0 were 89.1% and 70.7% compared to 83.3% and 62.9% in N1 situations. The 2-year and 5-year survival rates for stage T1 were 87.9% and 73.6% compared to 87.2% and 65.3% in stage T2, respectively. The time to recurrence in stage N0 was 35.1 ± 30.5 months compared to 25.63 ± 24.6 months in cases with N1 disease. Stage T1 was associated with a time to recurrence of 38.1 ± 33.9 months compared with 27.2 ± 22.7 months in patients classified T2.
Variables found to be strongly associated with survival in the univariate analysis included older age, higher tumour and N stage, and grading. Age, tumour stage (p = 0.011, 95% CI, 1.09 to 2.0), nodal stage (p = 0.038, 95% CI, 1.02 to 2.07), and recurrence were independently and significantly associated with survival in the multivariate analysis.

Conclusions

This confirms a high overall disease free survival for patients with T1 and N0 treated with single modality surgery and in common with the literature confirms the poor impact on prognosis of the N positive neck.
Appendix
Available only for authorised users
Literature
1.
go back to reference Shah JP, Gil Z: Current concepts in management of oral cancer–surgery. Oral Oncol. 2009, 45 (4–5): 394-401.CrossRefPubMed Shah JP, Gil Z: Current concepts in management of oral cancer–surgery. Oral Oncol. 2009, 45 (4–5): 394-401.CrossRefPubMed
2.
go back to reference Shingaki S, Takada M, Sasai K, Bibi R, Kobayashi T, Nomura T, Saito C: Impact of lymph node metastasis on the pattern of failure and survival in oral carcinomas. Am J Surg. 2003, 185 (3): 278-284. 10.1016/S0002-9610(02)01378-8.CrossRefPubMed Shingaki S, Takada M, Sasai K, Bibi R, Kobayashi T, Nomura T, Saito C: Impact of lymph node metastasis on the pattern of failure and survival in oral carcinomas. Am J Surg. 2003, 185 (3): 278-284. 10.1016/S0002-9610(02)01378-8.CrossRefPubMed
3.
go back to reference Mücke T, Koschinski J, Wagenpfeil S, Wolff KD, Kanatas A, Mitchell DA, Deppe H, Kesting MR: Functional outcome after different oncological interventions in head and neck cancer patients. J Cancer Res Clin Oncol. 2012, 138 (3): 371-376. 10.1007/s00432-011-1106-x.CrossRefPubMed Mücke T, Koschinski J, Wagenpfeil S, Wolff KD, Kanatas A, Mitchell DA, Deppe H, Kesting MR: Functional outcome after different oncological interventions in head and neck cancer patients. J Cancer Res Clin Oncol. 2012, 138 (3): 371-376. 10.1007/s00432-011-1106-x.CrossRefPubMed
4.
go back to reference Bar Ad V, Chalian A: Management of clinically negative neck for the patients with head and neck squamous cell carcinomas in the modern era. Oral Oncol. 2008, 44 (9): 817-822. 10.1016/j.oraloncology.2007.12.003.CrossRefPubMed Bar Ad V, Chalian A: Management of clinically negative neck for the patients with head and neck squamous cell carcinomas in the modern era. Oral Oncol. 2008, 44 (9): 817-822. 10.1016/j.oraloncology.2007.12.003.CrossRefPubMed
5.
go back to reference Elsheikh MN, Rinaldo A, Ferlito A, Fagan JJ, Suarez C, Lowry J, Paleri V, Khafif A, Olofsson J: Elective supraomohyoid neck dissection for oral cavity squamous cell carcinoma: is dissection of sublevel IIB necessary?. Oral Oncol. 2008, 44 (3): 216-219. 10.1016/j.oraloncology.2007.06.006.CrossRefPubMed Elsheikh MN, Rinaldo A, Ferlito A, Fagan JJ, Suarez C, Lowry J, Paleri V, Khafif A, Olofsson J: Elective supraomohyoid neck dissection for oral cavity squamous cell carcinoma: is dissection of sublevel IIB necessary?. Oral Oncol. 2008, 44 (3): 216-219. 10.1016/j.oraloncology.2007.06.006.CrossRefPubMed
6.
go back to reference Mücke T, Wolff KD, Wagenpfeil S, Mitchell DA, Hölzle F: Immediate microsurgical reconstruction after tumor ablation predicts survival among patients with head and neck carcinoma. Ann Surg Oncol. 2010, 17 (1): 287-295. 10.1245/s10434-009-0758-0.CrossRefPubMed Mücke T, Wolff KD, Wagenpfeil S, Mitchell DA, Hölzle F: Immediate microsurgical reconstruction after tumor ablation predicts survival among patients with head and neck carcinoma. Ann Surg Oncol. 2010, 17 (1): 287-295. 10.1245/s10434-009-0758-0.CrossRefPubMed
7.
go back to reference Brown JS, Magennis P, Rogers SN, Cawood JI, Howell R, Vaughan ED: Trends in head and neck microvascular reconstructive surgery in Liverpool (1992–2001). Br J Oral Maxillofac Surg. 2006, 44 (5): 364-370. 10.1016/j.bjoms.2005.07.018.CrossRefPubMed Brown JS, Magennis P, Rogers SN, Cawood JI, Howell R, Vaughan ED: Trends in head and neck microvascular reconstructive surgery in Liverpool (1992–2001). Br J Oral Maxillofac Surg. 2006, 44 (5): 364-370. 10.1016/j.bjoms.2005.07.018.CrossRefPubMed
8.
go back to reference Brown JS, Rogers SN, Lowe D: A comparison of tongue and soft palate squamous cell carcinoma treated by primary surgery in terms of survival and quality of life outcomes. Int J Oral Maxillofac Surg. 2006, 35 (3): 208-214. 10.1016/j.ijom.2005.09.005.CrossRefPubMed Brown JS, Rogers SN, Lowe D: A comparison of tongue and soft palate squamous cell carcinoma treated by primary surgery in terms of survival and quality of life outcomes. Int J Oral Maxillofac Surg. 2006, 35 (3): 208-214. 10.1016/j.ijom.2005.09.005.CrossRefPubMed
9.
go back to reference Zhang T, Lubek JE, Salama A, Dyalram D, Liu X, Ord RA: Treatment of cT1N0M0 tongue cancer: outcome and prognostic parameters. J Oral Maxillofac Surg. 2013, 72 (2): 406-414.CrossRefPubMed Zhang T, Lubek JE, Salama A, Dyalram D, Liu X, Ord RA: Treatment of cT1N0M0 tongue cancer: outcome and prognostic parameters. J Oral Maxillofac Surg. 2013, 72 (2): 406-414.CrossRefPubMed
10.
go back to reference Woolgar JA: Histopathological prognosticators in oral and oropharyngeal squamous cell carcinoma. Oral Oncol. 2006, 42 (3): 229-239. 10.1016/j.oraloncology.2005.05.008.CrossRefPubMed Woolgar JA: Histopathological prognosticators in oral and oropharyngeal squamous cell carcinoma. Oral Oncol. 2006, 42 (3): 229-239. 10.1016/j.oraloncology.2005.05.008.CrossRefPubMed
11.
go back to reference Fakih AR, Rao RS, Patel AR: Prophylactic neck dissection in squamous cell carcinoma of oral tongue: a prospective randomized study. Semin Surg Oncol. 1989, 5 (5): 327-330. 10.1002/ssu.2980050507.CrossRefPubMed Fakih AR, Rao RS, Patel AR: Prophylactic neck dissection in squamous cell carcinoma of oral tongue: a prospective randomized study. Semin Surg Oncol. 1989, 5 (5): 327-330. 10.1002/ssu.2980050507.CrossRefPubMed
12.
go back to reference Ho CM, Lam KH, Wei WI, Lau SK, Lam LK: Occult lymph node metastasis in small oral tongue cancers. Head Neck. 1992, 14 (5): 359-363. 10.1002/hed.2880140504.CrossRefPubMed Ho CM, Lam KH, Wei WI, Lau SK, Lam LK: Occult lymph node metastasis in small oral tongue cancers. Head Neck. 1992, 14 (5): 359-363. 10.1002/hed.2880140504.CrossRefPubMed
13.
go back to reference Kligerman J, Lima RA, Soares JR, Prado L, Dias FL, Freitas EQ, Olivatto LO: Supraomohyoid neck dissection in the treatment of T1/T2 squamous cell carcinoma of oral cavity. Am J Surg. 1994, 168 (5): 391-394. 10.1016/S0002-9610(05)80082-0.CrossRefPubMed Kligerman J, Lima RA, Soares JR, Prado L, Dias FL, Freitas EQ, Olivatto LO: Supraomohyoid neck dissection in the treatment of T1/T2 squamous cell carcinoma of oral cavity. Am J Surg. 1994, 168 (5): 391-394. 10.1016/S0002-9610(05)80082-0.CrossRefPubMed
14.
go back to reference Yuen AP, Ho CM, Chow TL, Tang LC, Cheung WY, Ng RW, Wei WI, Kong CK, Book KS, Yuen WC, Trendell-Smith NJ, Chan YW, Wong BY, Li GK, Ho AC, Womg SY, Yao TJ: Prospective randomized study of selective neck dissection versus observation for N0 neck of early tongue carcinoma. Head Neck. 2009, 31 (6): 765-772. 10.1002/hed.21033.CrossRefPubMed Yuen AP, Ho CM, Chow TL, Tang LC, Cheung WY, Ng RW, Wei WI, Kong CK, Book KS, Yuen WC, Trendell-Smith NJ, Chan YW, Wong BY, Li GK, Ho AC, Womg SY, Yao TJ: Prospective randomized study of selective neck dissection versus observation for N0 neck of early tongue carcinoma. Head Neck. 2009, 31 (6): 765-772. 10.1002/hed.21033.CrossRefPubMed
15.
go back to reference Weiss MH, Harrison LB, Isaacs RS: Use of decision analysis in planning a management strategy for the stage N0 neck. Arch Otolaryngol Head Neck Surg. 1994, 120 (7): 699-702. 10.1001/archotol.1994.01880310005001.CrossRefPubMed Weiss MH, Harrison LB, Isaacs RS: Use of decision analysis in planning a management strategy for the stage N0 neck. Arch Otolaryngol Head Neck Surg. 1994, 120 (7): 699-702. 10.1001/archotol.1994.01880310005001.CrossRefPubMed
16.
go back to reference Leon X, Quer M, Orus C, Sancho FJ, Bague S, Burgues J: Selective dissection of levels II-III with intraoperative control of the upper and middle jugular nodes: a therapeutic option for the N0 neck. Head Neck. 2001, 23 (6): 441-446. 10.1002/hed.1148.CrossRefPubMed Leon X, Quer M, Orus C, Sancho FJ, Bague S, Burgues J: Selective dissection of levels II-III with intraoperative control of the upper and middle jugular nodes: a therapeutic option for the N0 neck. Head Neck. 2001, 23 (6): 441-446. 10.1002/hed.1148.CrossRefPubMed
17.
go back to reference Wolff KD, Follmann M, Nast A: The diagnosis and treatment of oral cavity cancer. Dtsch Arztebl Int. 2012, 109 (48): 829-835.PubMedPubMedCentral Wolff KD, Follmann M, Nast A: The diagnosis and treatment of oral cavity cancer. Dtsch Arztebl Int. 2012, 109 (48): 829-835.PubMedPubMedCentral
Metadata
Title
Incidence and outcome for patients with occult lymph node involvement in T1 and T2 oral squamous cell carcinoma: a prospective study
Publication date
01-12-2014
Published in
BMC Cancer / Issue 1/2014
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/1471-2407-14-346

Other articles of this Issue 1/2014

BMC Cancer 1/2014 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine